短葶飞蓬云南三个种群的核型与等位酶分析

通过核型和等位酶分析,对短葶飞蓬（Erigeron breviscapus)种群遗传结构进行了较全面的研究。研究材料来自丽江,昆明,邱北,核型分析表明,这3个种群都为二倍体种群（2n=2x=18),以丽江种群为例,短葶飞蓬核型为2n=2x=18=6m 10sm(2SAT) 2st,10种酶的等位酶分析表明,短葶飞蓬的遗传变异存在于种群内,种群间遗传一致度高（I=0.9172),遗传距离小（D=0.0876),遗传距离与空间距离大致成正相关。     

Highly efficient conversion of lactate to pyruvate using whole cells of Acinetobacter sp

On an industrial scale, the production of pyruvate at a high concentration from the cheaper lactate substrate is a valuable process. To produce pyruvate from lactate by whole cells, various lactate-utilizing microorganisms were isolated from soil samples. Among them, strain WLIS, identified as Acinetobacter sp., was screened as a pyruvate producer. For the pyruvate preparation from lactate, the preparative conditions were optimized with whole cells of the strain. The cells cultivated in the medium containing 100 mM of l-lactate showed the highest biotransformation efficiency from lactate to pyruvate. The optimized dry-cell concentration, pH, and temperature of reaction were 6 g/L, pH 7.0-7.5, and 30 degrees C, respectively. The influences of ethylenediaminetetraacetic acid (EDTA) and aeration on a biotransformation reaction were carried out under the test conditions. Under the optimized reaction conditions, l-lactate at concentrations of 200 and 500 mM were almost totally stoichiometrically converted into pyruvate in 8 and 12 h, respectively. About 60% of 800 mM of l-lactate was transformed into pyruvate in 24 h. This reduced conversion rate is probably due to the high substrate inhibition in biotransformation.     

FKBP12.6 protects heart from AngII‐induced hypertrophy through inhibiting Ca2+/calmodulin‐mediated signalling pathways in vivo and in vitro

We previously observed that disruption of FK506‐binding protein 12.6 (FKBP12.6) gene resulted in cardiac hypertrophy in male mice. Studies showed that overexpression of FKBP12.6 attenuated thoracic aortic constriction (TAC)‐induced cardiac hypertrophy in mice, whereas the adenovirus‐mediated overexpression of FKBP12.6 induced hypertrophy and apoptosis in cultured neonatal cardiomyocytes, indicating that the role of FKBP12.6 in cardiac hypertrophy is still controversial. In this study, we aimed to investigate the roles and mechanisms of FKBP12.6 in angiotensin II (AngII)‐induced cardiac hypertrophy using various transgenic mouse models in vivo and in vitro. FKBP12.6 knockout (FKBP12.6^?/?) mice and cardiac‐specific FKBP12.6 overexpressing (FKBP12.6 TG) mice were infused with AngII (1500 ng/kg/min) for 14 days subcutaneously by implantation of an osmotic mini‐pump. The results showed that FKBP12.6 deficiency aggravated AngII‐induced cardiac hypertrophy, while cardiac‐specific overexpression of FKBP12.6 prevented hearts from the hypertrophic response to AngII stimulation in mice. Consistent with the results in vivo, overexpression of FKBP12.6 in H9c2 cells significantly repressed the AngII‐induced cardiomyocyte hypertrophy, seen as reductions in the cell sizes and the expressions of hypertrophic genes. Furthermore, we demonstrated that the protection of FKBP12.6 on AngII‐induced cardiac hypertrophy was involved in reducing the concentration of intracellular Ca²⁺ ([Ca²⁺]i), in which the protein significantly inhibited the key Ca²⁺/calmodulin‐dependent signalling pathways such as calcineurin/cardiac form of nuclear factor of activated T cells 4 (NFATc4), calmodulin kinaseII (CaMKII)/MEF‐2, AKT/Glycogen synthase kinase 3β (GSK3β)/NFATc4 and AKT/mTOR signalling pathways. Our study demonstrated that FKBP12.6 protects heart from AngII‐induced cardiac hypertrophy through inhibiting Ca²⁺/calmodulin‐mediated signalling pathways.     

In Search of a Consistent Solution to Allocation of Joint Production

Three consistency problems are identified that arise when partitioning a product system with joint production according to an allocation key, such as revenue or mass of the joint products, namely: lacking consistency of rationales and procedures; lacking consistency of monetary, mass, and energy balances in the partitioned product systems; and lacking consistency of results across model resolution and classification of the intermediate flows. Different solutions to these consistency problems are described, including the attempt of ecoinvent to solve the third consistency problem with a system model that uses revenue allocation at the point of substitution. The problems with the different practical implementations are described. For each of the three consistency problems, a solution is proposed and combined into a single consistent solution. The consistency of rationales and procedures is ensured by asking only one question at a time and performing a separate allocation and calculation for each question. The problem of maintaining monetary, mass, and energy balances is solved by a generalized allocation correction. The identified problem with consistency of results across model resolution and classification is solved by redefining the point of substitution. It is described what consequences the solutions will have if their results are misused for decision making that will shift demand between products.     

野生大黑蚁中抗菌肽类物质的分离纯化及其耐热性

以野生大黑蚁为原料,采用索氏抽提法除脂后,经乙醇浸提法粗提,再利用透析法分离纯化,得到对细菌具有抑制作用的抗菌肽类物质,并对该抗菌肽类物质进行氨基酸分析和耐热性检测。结果表明：分离得到的抗菌肽类物质对枯草芽胞杆菌具有抑制作用,其抑菌圈直径为24 mm;结合索氏抽提除脂,乙醇浸提和透析法所得到的粗提物氨基酸含量较高;蚂蚁抗菌肽类物质表现出较高的热稳定性,80 ℃下加热50 min后抑菌活性下降。     

基于响应面分析的高抗原活性猪水肿病大肠杆菌疫苗培养基的研制及效果评价

【背景】猪水肿病大肠杆菌引发的疾病造成了很大的危害,但现有培养基存在培养密度低的问题。【目的】研制出高抗原活性猪水肿病大肠杆菌疫苗培养基。【方法】以常用的市售猪水肿培养基为对照,通过单因素试验、爬坡试验(Plackett-Burman, PB)、响应面(Box-Behnken, BB)试验对猪水肿培养基进行响应面优化,得到猪水肿培养基最优配方。以响应面试验得到的培养基培养猪水肿病大肠杆菌,评价不同培养时间点菌株的抗原活性,制作灭活疫苗,进行动物免疫保护试验。【结果】对研制的培养基进行扩大培养验证,发现扩大培养得到的菌株活菌数可达5×10⁹ CFU/mL以上,约为对照组的2倍。制备的灭活疫苗效价可达1:140 000,并在9 h时抗原蛋白效价达到最高。【结论】本研究研制出的疫苗培养基显著提高了猪大肠杆菌菌体密度,并可提高菌体抗原活性,为猪水肿病灭活疫苗的制备提供了技术指引。     

菌核多孔菌培养特性及驯化栽培

为了充分开发利用菌核多孔菌Polyporus tuberaster资源,对采自吉林省露水河东升林场的野生菌核多孔菌进行分离纯化获取纯菌株作为实验材料,采用十字划线法研究固体培养条件下不同碳源、氮源、pH和温度对其菌丝生长的影响,从以上4个单因素实验中选出3个最优水平进行正交实验。结果表明,菌核多孔菌P. tuberaster的最适培养条件为：碳源糊精粉（20mg/mL）、氮源酵母浸粉（2mg/mL）、pH 5.0、温度25℃。在最适培养条件下采用试剂盒测定液体培养条件下菌株的产酶活力,结果表明,菌核多孔菌产漆酶能力较强,酶活力最高可达386.96U/L;木质素过氧化物酶活力仅为5.23U/L;未检测到锰过氧化物酶。出菇实验中,二级种选用麦粒菌种,500mL罐头瓶装干料160g,每瓶接种蚕豆大小菌块3-4块,25℃培养,菌丝满瓶时间为20d;栽培种配方为阔叶树木屑78%、麦麸20%、石灰粉1%、石膏1%、含水量65%左右,17cm×33cm×0.05cm栽培袋装干料520g,每袋接种蚕豆大小二级种3-4块,菌丝发菌时间为26d;在92%-95%空气湿度、一定散射光和20-21℃低温刺激下培养13d后原基分化形成菇蕾,此后加大空气湿度至97%-98%并保持温度24-25℃培养32d后子实体成熟。